Humana Inc. (NYSE:HUM) Stock Position Raised by Plimoth Trust Co. LLC

Plimoth Trust Co. LLC boosted its stake in shares of Humana Inc. (NYSE:HUM) by 39.5% in the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,018 shares of the insurance provider’s stock after acquiring an additional 288 shares during the quarter. Plimoth Trust Co. LLC’s holdings in Humana were worth $353,000 as of its most recent SEC filing.

A number of other hedge funds have also made changes to their positions in HUM. Norges Bank acquired a new stake in Humana in the 4th quarter valued at about $676,800,000. Sanders Capital LLC bought a new position in Humana in the 4th quarter worth approximately $489,300,000. Putnam Investments LLC lifted its holdings in Humana by 550.3% during the 4th quarter. Putnam Investments LLC now owns 875,489 shares of the insurance provider’s stock worth $400,808,000 after buying an additional 740,858 shares in the last quarter. Allspring Global Investments Holdings LLC boosted its position in Humana by 255.4% in the 1st quarter. Allspring Global Investments Holdings LLC now owns 620,793 shares of the insurance provider’s stock valued at $215,241,000 after buying an additional 446,124 shares during the last quarter. Finally, Ameriprise Financial Inc. increased its stake in shares of Humana by 35.9% in the 3rd quarter. Ameriprise Financial Inc. now owns 1,523,835 shares of the insurance provider’s stock valued at $741,409,000 after buying an additional 402,559 shares during the period. Institutional investors and hedge funds own 92.38% of the company’s stock.

Humana Stock Performance

HUM opened at $362.85 on Thursday. The company has a debt-to-equity ratio of 0.77, a current ratio of 1.67 and a quick ratio of 1.67. The company has a market capitalization of $43.72 billion, a price-to-earnings ratio of 22.59, a P/E/G ratio of 2.16 and a beta of 0.51. The business’s 50-day moving average price is $345.69 and its two-hundred day moving average price is $350.79. Humana Inc. has a 1 year low of $298.61 and a 1 year high of $530.54.

Humana (NYSE:HUM) last released its earnings results on Wednesday, April 24th. The insurance provider reported $7.23 EPS for the quarter, beating the consensus estimate of $6.12 by $1.11. The firm had revenue of $29.61 billion for the quarter, compared to analysts’ expectations of $28.52 billion. Humana had a return on equity of 17.76% and a net margin of 1.82%. The business’s quarterly revenue was up 10.7% compared to the same quarter last year. During the same quarter in the previous year, the business posted $9.38 EPS. Equities analysts expect that Humana Inc. will post 16.27 EPS for the current fiscal year.

Humana Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, July 26th. Investors of record on Friday, June 28th will be given a $0.885 dividend. This represents a $3.54 dividend on an annualized basis and a yield of 0.98%. The ex-dividend date of this dividend is Friday, June 28th. Humana’s dividend payout ratio (DPR) is currently 22.04%.

Analyst Ratings Changes

Several research firms recently issued reports on HUM. Jefferies Financial Group decreased their price target on Humana from $411.00 to $381.00 and set a “buy” rating on the stock in a report on Monday, April 22nd. TD Cowen lowered their price target on shares of Humana from $427.00 to $396.00 and set a “buy” rating for the company in a research report on Tuesday, April 2nd. UBS Group cut their price objective on shares of Humana from $334.00 to $326.00 and set a “neutral” rating on the stock in a report on Thursday, April 25th. Wells Fargo & Company dropped their target price on shares of Humana from $413.00 to $350.00 and set an “overweight” rating for the company in a research report on Monday, April 8th. Finally, Cantor Fitzgerald restated a “neutral” rating and issued a $360.00 price target on shares of Humana in a research report on Wednesday, June 12th. Fourteen research analysts have rated the stock with a hold rating and nine have issued a buy rating to the company’s stock. According to data from MarketBeat.com, the stock has a consensus rating of “Hold” and an average price target of $409.55.

Humana Company Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.